Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Attention deficit/hyperactivity disorder
ADR ID BADD_A00383
ADR Hierarchy
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.04      Attention deficit and disruptive behaviour disorders
19.21.04.001      Attention deficit/hyperactivity disorder
Description A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V) [MeSH]
MedDRA Code 10003736
MeSH ID D001289
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
ADD | ADDH | Attention deficit disorder | Attention deficit disorder of childhood | Attention deficit disorder of childhood with hyperactivity | Attention deficit disorder of childhood without mention of hyperactivity | Attention deficit-hyperactivity disorder | Attention deficit/hyperactivity disorder | Attention deficit/hyperactivity disorder NOS | Hyperactive child syndrome | Hyperkinesis of childhood with developmental delay | Hyperkinetic conduct disorder of childhood | Hyperkinetic syndrome | Hyperkinetic syndrome of childhood | Other specified manifestations of hyperkinetic syndrome of childhood | Overactive child | Syndrome hyperkinetic | Unspecified hyperkinetic syndrome of childhood | Hyperactivity syndrome aggravated | ADHD | ADHD, combined type | ADHD, predominantly hyperactive-impulsive type | ADHD, predominantly inattentive type | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorders with Hyperactivity | Attention Deficit Hyperactivity Disorders | Attention Deficit-Hyperactivity Disorder | Attention Deficit-Hyperactivity Disorders | Deficit-Hyperactivity Disorder, Attention | Deficit-Hyperactivity Disorders, Attention | Disorder, Attention Deficit-Hyperactivity | Disorders, Attention Deficit-Hyperactivity | Hyperkinetic Syndrome | Syndromes, Hyperkinetic | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention Deficit Disorders | Deficit Disorder, Attention | Deficit Disorders, Attention | Disorder, Attention Deficit | Disorders, Attention Deficit | Brain Dysfunction, Minimal | Dysfunction, Minimal Brain | Minimal Brain Dysfunction
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00165Aripiprazole0.001526%
BADD_D00180Atomoxetine0.003472%
BADD_D00356Carbamazepine0.002105%
BADD_D00475Citalopram0.000083%
BADD_D00501Clonazepam--
BADD_D00502Clonidine0.000206%
BADD_D00680Dimethyl fumarate--
BADD_D00749Efavirenz0.050464%
BADD_D00809Escitalopram0.000142%
BADD_D00812Eslicarbazepine acetate--
BADD_D00879Fentanyl--
BADD_D00898Finasteride0.003421%
BADD_D00932Fluoxetine0.001271%
BADD_D00981Gabapentin0.000076%
BADD_D01003Ganciclovir--
BADD_D01213Isotretinoin0.002526%
BADD_D01243Lamotrigine0.003995%
BADD_D01265Levetiracetam0.001333%
BADD_D01275Levofloxacin0.000260%
BADD_D01281Levonorgestrel--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01431Methylphenidate0.002112%
BADD_D01496Montelukast0.000208%
BADD_D01547Nefazodone hydrochloride--
BADD_D01572Nitisinone0.064083%
BADD_D01617Ondansetron0.000949%
BADD_D01637Oxcarbazepine0.001247%
BADD_D01679Paroxetine0.002057%
BADD_D01765Phenytoin0.000819%
BADD_D01834Prednisone0.000040%
The 1th Page    1 2    Next   Last    Total 2 Pages